<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff1; src: url("1.otf"); }
.f1 { font-family:ff1,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff3; src: url("3.otf"); }
.f2 { font-family:ff3,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff9; src: url("9.otf"); }
.f3 { font-family:ff9,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff6; src: url("6.otf"); }
.f4 { font-family:ff6,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff2; src: url("2.otf"); }
.f5 { font-family:ff2,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff7; src: url("7.otf"); }
.f6 { font-family:ff7,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff8; src: url("8.otf"); }
.f7 { font-family:ff8,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff11; src: url("11.otf"); }
.f8 { font-family:ff11,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff4; src: url("4.otf"); }
.f9 { font-family:ff4,serif; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img style="position:absolute; left:0px; top:0px;" width="612" height="792" src="page8.png"">
<div class="txt" style="position:absolute; left:78px; top:36px;"><span class="f9" style="font-size:7px;vertical-align:baseline;color:rgba(145,148,150,1);">Research article</span></div>
<div class="txt" style="position:absolute; left:444px; top:36px;"><span class="f9" style="font-size:7px;vertical-align:baseline;color:rgba(23,163,216,1);">Microbiology and Infectious Disease</span></div>
<div class="txt" style="position:absolute; left:168px; top:53px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">reporter output (</span><span class="f2" style="font-size:8px;vertical-align:baseline;color:rgba(109,109,112,1);">Figure 3E</span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">). These results show</span></div>
<div class="txt" style="position:absolute; left:168px; top:65px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">that the dynamic response of WT to polyamines</span></div>
<div class="txt" style="position:absolute; left:168px; top:77px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">requires MbaA. We suspect that the minor reduc-</span></div>
<div class="txt" style="position:absolute; left:168px; top:89px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">tion in biofilm production that occurred in the</span></div>
<div class="txt" style="position:absolute; left:168px; top:101px;"><span class="f3" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">D</span><span class="f4" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">mbaA </span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">mutant when supplied polyamines is due</span></div>
<div class="txt" style="position:absolute; left:168px; top:113px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">to non-specific effects, perhaps via interaction of</span></div>
<div class="txt" style="position:absolute; left:168px; top:125px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">polyamines with negatively charged matrix com-</span></div>
<div class="txt" style="position:absolute; left:168px; top:137px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">ponents. We next investigated the role of the</span></div>
<div class="txt" style="position:absolute; left:168px; top:149px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">polyamine periplasmic binding protein NspS that</span></div>
<div class="txt" style="position:absolute; left:168px; top:161px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">transmits polyamine information to MbaA. In the</span></div>
<div class="txt" style="position:absolute; left:168px; top:173px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">absence of its partner polyamine binding protein,</span></div>
<div class="txt" style="position:absolute; left:168px; top:185px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">NspS, MbaA is thought to function as a constitu-</span></div>
<div class="txt" style="position:absolute; left:168px; top:197px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">tive phosphodiesterase (</span><span class="f2" style="font-size:8px;vertical-align:baseline;color:rgba(109,109,112,1);">Cockerell et al., 2014</span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">).</span></div>
<div class="txt" style="position:absolute; left:168px; top:209px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">Consistent with this model, deletion of </span><span class="f4" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">nspS </span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">in an</span></div>
<div class="txt" style="position:absolute; left:168px; top:221px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">otherwise WT strain reduced overall peak biofilm</span></div>
<div class="txt" style="position:absolute; left:168px; top:233px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">biomass by 65% and dispersal initiated 4 hr prior</span></div>
<div class="txt" style="position:absolute; left:168px; top:245px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">to when dispersal begins in the WT (</span><span class="f2" style="font-size:8px;vertical-align:baseline;color:rgba(109,109,112,1);">Figure 3â€”</span></div>
<div class="txt" style="position:absolute; left:168px; top:257px;"><span class="f2" style="font-size:8px;vertical-align:baseline;color:rgba(109,109,112,1);">figure supplement 1</span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">). In the </span><span class="f3" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">D</span><span class="f4" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">nspS </span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">mutant, c-di-</span></div>
<div class="txt" style="position:absolute; left:168px; top:269px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">GMP levels were lower than in the WT as judged</span></div>
<div class="txt" style="position:absolute; left:168px; top:281px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">by the c-di-GMP reporter (</span><span class="f2" style="font-size:8px;vertical-align:baseline;color:rgba(109,109,112,1);">Figure 3F</span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">), showing</span></div>
<div class="txt" style="position:absolute; left:168px; top:293px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">that MbaA is locked as a constitutive phosphodi-</span></div>
<div class="txt" style="position:absolute; left:168px; top:305px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">esterase. Exogenous addition of polyamines had</span></div>
<div class="txt" style="position:absolute; left:168px; top:317px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">no effect on c-di-GMP levels (</span><span class="f2" style="font-size:8px;vertical-align:baseline;color:rgba(109,109,112,1);">Figure 3F</span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">).</span></div>
<div class="txt" style="position:absolute; left:168px; top:329px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">Together, these findings demonstrate that the</span></div>
<div class="txt" style="position:absolute; left:168px; top:341px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">WT </span><span class="f4" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">V. cholerae </span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">response to polyamines is con-</span></div>
<div class="txt" style="position:absolute; left:168px; top:353px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">trolled by the NspS-MbaA polyamine sensing</span></div>
<div class="txt" style="position:absolute; left:168px; top:365px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">circuit.</span></div>
<div class="txt" style="position:absolute; left:377px; top:266px;"><span class="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Video 2. </span><span class="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Representative time-lapse images of the</span></div>
<div class="txt" style="position:absolute; left:377px; top:277px;"><span class="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">biofilm lifecycles of the </span><span class="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">mbaA-3xFLAG</span><span class="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">,</span></div>
<div class="txt" style="position:absolute; left:377px; top:287px;"><span class="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">mbaA</span><span class="f7" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">EVL*</span><span class="f8" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Ã€</span><span class="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">3xFLAG</span><span class="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">, and </span><span class="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">mbaA</span><span class="f7" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">SGDEF*</span><span class="f8" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Ã€</span><span class="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">3xFLAG V.</span></div>
<div class="txt" style="position:absolute; left:377px; top:299px;"><span class="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">cholerae </span><span class="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">strains following treatment with water (Ctrl),</span></div>
<div class="txt" style="position:absolute; left:377px; top:310px;"><span class="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">100 </span><span class="f3" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">m</span><span class="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">M norspermidine (Nspd), or 100 </span><span class="f3" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">m</span><span class="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">M spermidine</span></div>
<div class="txt" style="position:absolute; left:377px; top:321px;"><span class="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(Spd).</span></div>
<div class="txt" style="position:absolute; left:377px; top:333px;"><a href="https://elifesciences.org/articles/65487#video2"><span class="f6" style="font-size:7px;vertical-align:baseline;color:rgba(23,163,216,1);">https://elifesciences.org/articles/65487#video2</span></a></div>
<div class="txt" style="position:absolute; left:168px; top:386px;"><span class="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">Both the MbaA EVL and SGDEF domains are required for MbaA to</span></div>
<div class="txt" style="position:absolute; left:168px; top:398px;"><span class="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">detect polyamines</span></div>
<div class="txt" style="position:absolute; left:168px; top:413px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">We wondered how the putative MbaA phosphodiesterase and diguanylate cyclase enzymatic activi-</span></div>
<div class="txt" style="position:absolute; left:168px; top:425px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">ties contribute to the </span><span class="f4" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">V. cholerae </span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">responses to norspermidine and spermidine. The cytoplasmic</span></div>
<div class="txt" style="position:absolute; left:168px; top:437px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">domain of MbaA exhibits phosphodiesterase but not diguanylate cyclase activity in vitro</span></div>
<div class="txt" style="position:absolute; left:168px; top:449px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span class="f2" style="font-size:8px;vertical-align:baseline;color:rgba(109,109,112,1);">Cockerell et al., 2014</span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">). We reasoned that, when an intact regulatory domain is present, MbaA</span></div>
<div class="txt" style="position:absolute; left:168px; top:461px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">could possess both enzymatic activities, with the activity of each domain inversely controlled by</span></div>
<div class="txt" style="position:absolute; left:168px; top:473px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">NspS binding. To probe the role of each domain, we introduced inactivating point mutations in the</span></div>
<div class="txt" style="position:absolute; left:168px; top:485px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">catalytic motifs. To ensure that our mutations did not destabilize MbaA, we first fused MbaA to</span></div>
<div class="txt" style="position:absolute; left:168px; top:497px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">3xFLAG and introduced the gene encoding the fusion onto the chromosome at the </span><span class="f4" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">mbaA </span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">locus.</span></div>
<div class="txt" style="position:absolute; left:168px; top:509px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">Tagging did not alter MbaA control over the biofilm lifecycle (</span><span class="f2" style="font-size:8px;vertical-align:baseline;color:rgba(109,109,112,1);">Figure 4â€”figure supplement 1A</span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">,</span></div>
<div class="txt" style="position:absolute; left:168px; top:521px;"><span class="f2" style="font-size:8px;vertical-align:baseline;color:rgba(109,109,112,1);">Video 2</span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">). To inactivate the MbaA phosphodiesterase activity, we substituted the conserved catalytic</span></div>
<div class="txt" style="position:absolute; left:168px; top:533px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">residue E553 with alanine, converting EVL to AVL (referred to as EVL* henceforth). This change did</span></div>
<div class="txt" style="position:absolute; left:168px; top:545px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">not alter MbaA-3xFLAG abundance (</span><span class="f2" style="font-size:8px;vertical-align:baseline;color:rgba(109,109,112,1);">Figure 4â€”figure supplement 1B</span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">). </span><span class="f4" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">V. cholerae </span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">harboring</span></div>
<div class="txt" style="position:absolute; left:168px; top:555px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">MbaA</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">EVL* </span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">exhibited an increase in biofilm biomass and a strong biofilm dispersal defect (</span><span class="f2" style="font-size:8px;vertical-align:baseline;color:rgba(109,109,112,1);">Figure 4A</span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">),</span></div>
<div class="txt" style="position:absolute; left:168px; top:569px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">and only a modest response to exogenous polyamines, with norspermidine eliciting some inhibition</span></div>
<div class="txt" style="position:absolute; left:168px; top:581px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">of biofilm dispersal and spermidine driving a small reduction in overall biofilm biomass (</span><span class="f2" style="font-size:8px;vertical-align:baseline;color:rgba(109,109,112,1);">Figure 4B</span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">,</span></div>
<div class="txt" style="position:absolute; left:168px; top:593px;"><span class="f2" style="font-size:8px;vertical-align:baseline;color:rgba(109,109,112,1);">Video 2</span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">). Treatment with norspermidine did increase c-di-GMP levels in </span><span class="f4" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">V. cholerae </span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">carrying</span></div>
<div class="txt" style="position:absolute; left:168px; top:603px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">MbaA</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">EVL* </span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">as judged by the reporter output (</span><span class="f2" style="font-size:8px;vertical-align:baseline;color:rgba(109,109,112,1);">Figure 4C</span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">), albeit not to the level of WT (</span><span class="f2" style="font-size:8px;vertical-align:baseline;color:rgba(109,109,112,1);">Figure 3C</span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">),</span></div>
<div class="txt" style="position:absolute; left:168px; top:615px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">suggesting that the </span><span class="f4" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">V. cholerae mbaA</span><span class="f4" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">EVL</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">* </span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">mutant, which is incapable of c-di-GMP degradation,</span></div>
<div class="txt" style="position:absolute; left:168px; top:629px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">retains the capacity to synthesize some c-di-GMP via the MbaA SGDEF domain. In contrast, the </span><span class="f4" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">V.</span></div>
<div class="txt" style="position:absolute; left:168px; top:639px;"><span class="f4" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">cholerae mbaA</span><span class="f4" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">EVL</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">* </span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">strain displayed little reduction in c-di-GMP levels in response to spermidine,</span></div>
<div class="txt" style="position:absolute; left:168px; top:653px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">presumably because it lacks the phosphodiesterase activity required to degrade c-di-GMP</span></div>
<div class="txt" style="position:absolute; left:168px; top:665px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span class="f2" style="font-size:8px;vertical-align:baseline;color:rgba(109,109,112,1);">Figure 4C</span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">). Thus, despite the fact that the purified cytoplasmic domain functioned only as a phos-</span></div>
<div class="txt" style="position:absolute; left:168px; top:677px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">phodiesterase in vitro, our results suggest that, in vivo, MbaA is capable of synthesizing c-di-GMP in</span></div>
<div class="txt" style="position:absolute; left:168px; top:689px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">the presence of norspermidine. To validate this prediction, we altered the conserved catalytic resi-</span></div>
<div class="txt" style="position:absolute; left:168px; top:701px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">dues D426 and E427 to alanine residues, yielding the inactive MbaA SGAAF variant (referred to as</span></div>
<div class="txt" style="position:absolute; left:168px; top:713px;"><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">SGDEF*). These substitutions did not affect protein levels (</span><span class="f2" style="font-size:8px;vertical-align:baseline;color:rgba(109,109,112,1);">Figure 4â€”figure supplement 1B</span><span class="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">). In</span></div>
<div class="txt" style="position:absolute; left:37px; top:748px;"><span class="f9" style="font-size:7px;vertical-align:baseline;color:rgba(109,109,112,1);">Bridges and Bassler. eLife 2021;10:e65487. DOI: </span><a href="https://doi.org/10.7554/eLife.65487"><span class="f9" style="font-size:7px;vertical-align:baseline;color:rgba(23,163,216,1);">https://doi.org/10.7554/eLife.65487</span></a></div>
<div class="txt" style="position:absolute; left:549px; top:748px;"><span class="f9" style="font-size:7px;vertical-align:baseline;color:rgba(101,104,108,1);">8 of 20</span></div>
</body>
</html>
